Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,452 | 121,510 | 132,320 | 92,334 | 181,920 |
| Receivables | 50,060 | 56,939 | 51,649 | 44,592 | 48,691 |
| Inventories | 134,881 | 134,608 | 152,591 | 158,912 | 156,432 |
| Other current assets | 3,213 | 3,569 | 18,641 | 18,479 | 12,757 |
| TOTAL | $286,320 | $326,046 | $355,201 | $314,317 | $399,800 |
| Non-Current Assets | |||||
| PPE Net | 390,583 | 379,722 | 377,941 | 396,168 | 394,994 |
| Investments And Advances | 1,191 | 1,228 | 1,670 | 1,992 | 4,288 |
| Intangibles | 736,650 | 738,145 | 879,822 | 881,721 | 884,266 |
| Other Non-Current Assets | 135,813 | 138,551 | 141,657 | 106,845 | 101,589 |
| TOTAL | $1,264,237 | $1,257,646 | $1,401,090 | $1,386,726 | $1,385,137 |
| Total Assets | $1,550,557 | $1,583,692 | $1,756,291 | $1,701,043 | $1,784,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 28,112 | 10,976 | 28,847 | 19,357 | 29,202 |
| Accounts payable and accrued liabilities | 20,134 | 28,093 | 29,194 | 36,988 | 33,285 |
| Accrued Expenses | 76,499 | 65,161 | 58,589 | 45,933 | 95,962 |
| Other current liabilities | N/A | N/A | N/A | N/A | 809 |
| TOTAL | $272,549 | $255,865 | $270,560 | $228,216 | $331,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 470,895 | 476,891 | 468,064 | 467,082 | 466,076 |
| Deferred Revenues | 41,046 | 47,834 | 50,066 | 44,796 | 86,619 |
| Other Non-Current Liabilities | 8,761 | 26,286 | 461 | 1,763 | 11,906 |
| TOTAL | $710,633 | $740,144 | $714,284 | $689,203 | $689,998 |
| Total Liabilities | $983,182 | $996,009 | $984,844 | $917,419 | $1,021,192 |
| Shareholders' Equity | |||||
| Common Shares | 1,728,356 | 1,617,093 | 1,704,809 | 1,700,008 | 1,607,452 |
| Retained earnings | -1,105,551 | -1,076,198 | -915,258 | -900,031 | -880,395 |
| Other shareholders' equity | -55,430 | -40,749 | -18,104 | -16,353 | 36,688 |
| TOTAL | $567,375 | $587,683 | $771,447 | $783,624 | $763,745 |
| Total Liabilities And Equity | $1,550,557 | $1,583,692 | $1,756,291 | $1,701,043 | $1,784,937 |